bFGF peptide combined with the pVAX-8CpG plasmid as adjuvant is a novel anticancer vaccine inducing effective immune responses against Lewis lung carcinoma

By Li Meng   Shi Hua Shan   Zhang Hai Long   Luo Zi Chao   Wan Yang   Lu Lian   Luo Shun-Tao   Yang Li  

Molecular Medicine Reports, Vol. 5, Iss. 3, 2012-03 ,pp. : 625-630

Spandidos Publications

Access to resources Recommend Favorite

Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9

By Zhang Yuyi   Lin Ang   Zhang Cai   Tian Zhigang   Zhang Jian  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 357-367

Springer Publishing Company

Access to resources Recommend Favorite

Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity

By Alteber Zoya   Azulay Meir   Cafri Gal   Vadai Ezra   Tzehoval Esther   Eisenbach Lea  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 369-380

Springer Publishing Company

Access to resources Recommend Favorite

TRAIL is involved in CpG ODN-mediated anti-apoptotic signals

By Lim Eun-Jung   Park Dae-Weon   Jeong Tae-Whal   Chin Byung-Rho   Bae Yoe-Sik   Baek Suk-Hwan  

Oncology Reports, Vol. 27, Iss. 4, 2012-04 ,pp. : 1213-1218

Spandidos Publications

Access to resources Recommend Favorite

The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma

By              

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 2103-2110

Spandidos Publications

Access to resources Recommend Favorite